Search

Your search keyword '"Chronic kidney failure -- Economic aspects"' showing total 46 results
Start Over Descriptor "Chronic kidney failure -- Economic aspects"
46 results on '"Chronic kidney failure -- Economic aspects"'

2. Reports Outline Kidney Disease Study Results from Fresenius Medical Care (A Systematic Review of the Cost-effectiveness of Renal Replacement Therapies, and Consequences for Decision-making In the End-stage Renal Disease Treatment Pathway)

Subjects
Fresenius Medical Care AG & Company KGaA, Cost benefit analysis -- Economic aspects, Chronic kidney failure -- Economic aspects, Health care industry -- Economic aspects, Health care industry, Cost benefit analysis, Health
Abstract

2024 MAY 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Kidney Diseases and Conditions - Kidney Disease have been presented. [...]

Published
2024

5. Peru : Fissal provides transparent information on the financing of high-cost diseases

Subjects
Chronic kidney failure -- Economic aspects, Health insurance -- Economic aspects, Company financing, Business, international
Abstract

In order to make known to the population, in a transparent manner, public information about its financing management of high-cost diseases, the Intangible Solidarity Health Fund Fissal, executing unit of [...]

Published
2023

6. Calliditas Announces Publication of Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with IgA Nephropathy in the United States

Subjects
Transplantation of organs, tissues, etc. -- Economic aspects, Medical research -- Economic aspects, Medicine, Experimental -- Economic aspects, Cost benefit analysis -- Economic aspects, Chronic kidney failure -- Economic aspects, Immunoglobulin A -- Economic aspects, Cost benefit analysis, Banking, finance and accounting industries, Tarpeyo (Medication)
Abstract

(GlobeNewswire) - Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (Calliditas), announced the publication of a cost-effective analysis of Nefecon (marketed in the United States as TARPEYO (budesonide) delayed release [...]

Published
2023

7. Calliditas Announces Publication of Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with IgA Nephropathy in the United States

Subjects
Transplantation of organs, tissues, etc. -- Economic aspects, Medical research -- Economic aspects, Medicine, Experimental -- Economic aspects, Cost benefit analysis -- Economic aspects, Chronic kidney failure -- Economic aspects, Immunoglobulin A -- Economic aspects, Cost benefit analysis, Banking, finance and accounting industries, Business, Tarpeyo (Medication)
Abstract

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ('Calliditas'), announced the publication of a cost-effective analysis of Nefecon (marketed in the United [...]

Published
2023

8. Leading Edge and Renalogic Announce Partnership - Lowering Dialysis Costs For 100,000 Health Plan Members

Subjects
Medical care, Cost of -- Economic aspects, Chronic kidney failure -- Economic aspects, Cost control -- Economic aspects, Health insurance -- Economic aspects, Cost reduction, General interest, News, opinion and commentary
Abstract

TAMPA: RENALOGIC has issued the following news release: Leading Edge Administrators ('Leading Edge') a leading third-party health administrator, today announced its exclusive partnership with Renalogic for dialysis cost containment services. [...]

Published
2023

9. Leading Edge and Renalogic Announce Partnership - Lowering Dialysis Costs For 100,000 Health Plan Members

Subjects
Medical care, Cost of -- Economic aspects, Chronic kidney failure -- Economic aspects, Cost control -- Economic aspects, Health insurance -- Economic aspects, Cost reduction, Business, Business, international
Abstract

TAMPA, Fla. -- Leading Edge Administrators ('Leading Edge') a leading third-party health administrator, today announced its exclusive partnership with Renalogic for dialysis cost containment services. With 20 years of expertise, [...]

Published
2023

10. Research from European University of Lefke Provide New Insights into COVID-19 (Risk of COVID-19 and Cost Burden in End-Stage Renal Disease Patients and Policy Implications for Managing Nephrology Services during the COVID-19 Pandemic)

Subjects
Epidemics -- Economic aspects, Chronic kidney failure -- Economic aspects, Company business management, Health
Abstract

2023 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Investigators publish new report on COVID-19. According to news originating from European University [...]

Published
2023

11. Bending the Cost Curve in End-Stage Kidney Disease

Subjects
United States. Department of Health and Human Services, Social service -- Economic aspects, Chronic kidney failure -- Economic aspects, General interest, News, opinion and commentary
Abstract

BROOMFIELD: Alio has issued the following news release: Alio and The Hargan Group are pleased to announce they will host a webinar 'Bending the Cost Curve in End-Stage Kidney Disease.' [...]

Published
2022

12. Bending the Cost Curve in End-Stage Kidney Disease

Subjects
United States. Department of Health and Human Services, Social service -- Economic aspects, Chronic kidney failure -- Economic aspects, Business, News, opinion and commentary
Abstract

Alio CEO and former US Deputy Secretary of Health and Human Services announce webinar on innovation and the future of kidney health BROOMFIELD, Colo., June 21, 2022 /PRNewswire/ -- Alio [...]

Published
2022

13. Feryal Clark ask the Secretary of State for Health and Social Care, with reference to the reimbursement of costs incurred from dialysis of patients with chronic kidney disease who are treated at home

Subjects
Chronic kidney failure -- Economic aspects, Business, international
Abstract

London: UK Parliament has issued the following written answer: Answer Maria Caulfield Answered on 24 May 2022 Provisions are in place for patients receiving haemodialysis treatment at home to be [...]

Published
2022

14. Elliot Colburn ask the Secretary of State for Health and Social Care, what recent assessment he has made of the cost to the NHS of the treatment of strokes and heart attacks in people with chronic kidney disease

Subjects
Heart attack -- Economic aspects, Stroke (Disease) -- Economic aspects, Chronic kidney failure -- Economic aspects, Business, international
Abstract

London: UK Parliament has issued the following written answer: Answer Maria Caulfield Answered on 1 December 2021 We have not made a specific assessment. Information on such costs is not [...]

Published
2021

17. Findings from D. Bhowmik and Colleagues Update Understanding of Male Kidney Diseases and Conditions (Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma)

Subjects
Health care costs -- Economic aspects, Physical fitness -- Economic aspects, Medical research -- Economic aspects, Multiple myeloma -- Economic aspects, Chronic kidney failure -- Economic aspects, Health
Abstract

2018 MAY 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Kidney Diseases and Conditions - Male Kidney [...]

Published
2018

18. Data from National Institute for Public Health and the Environment Update Knowledge in Kidney Disease (Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs)

Subjects
Transplantation of organs, tissues, etc. -- Economic aspects, Medical research -- Economic aspects, Medicine, Experimental -- Economic aspects, Medical care, Cost of -- Economic aspects, Chronic kidney failure -- Economic aspects, Public health -- Economic aspects, Health
Abstract

2021 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on kidney disease are presented in a new report. According to [...]

Published
2021

19. Renalogic Introduces CareINSIGHTS.ai The Complete Intervention Program That Puts an End to Surprise Catastrophic Dialysis Claims Costs

Subjects
Health care costs -- Economic aspects, Cost control -- Economic aspects, Infection control -- Economic aspects, Chronic kidney failure -- Economic aspects, Cost reduction, Business, Business, international
Abstract

Cost containment alone is no longer the gold standard when it comes to managing risks associated with Chronic Kidney Disease (CKD). It's better to avoid catastrophic dialysis and CKD claims [...]

Published
2020

20. Researchers at RTI International Target Chronic Kidney Disease (The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease)

Subjects
Physical fitness -- Economic aspects, Hemoglobins -- Economic aspects, Anemia -- Economic aspects, Chronic kidney failure -- Economic aspects, Health
Abstract

2017 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Kidney Diseases and Conditions - Chronic Kidney Disease [...]

Published
2017

21. Nanjing Medical University Researchers Broaden Understanding of Chronic Kidney Disease (Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness ...)

Subjects
Hyperparathyroidism -- Economic aspects, Medical research -- Economic aspects, Medicine, Experimental -- Economic aspects, Parathyroid hormone -- Economic aspects, Cost benefit analysis -- Economic aspects, Chronic kidney failure -- Economic aspects, Cinacalcet -- Economic aspects, Paricalcitol -- Economic aspects, Cost benefit analysis, Health
Abstract

2021 AUG 6 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in chronic kidney disease. According to news reporting out [...]

Published
2021

22. Researchers at Lahey Hospital and Medical Center Target Acute Coronary Syndrome (Cost-effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention In Patients With Chronic Kidney Disease and Acute Coronary Syndromes ...)

Subjects
United States. National Institutes of Health, Medical research -- Economic aspects, Medicine, Experimental -- Economic aspects, Coronary heart disease -- Economic aspects, Coronary artery bypass -- Economic aspects, Medical centers -- Economic aspects, Chronic kidney failure -- Economic aspects, Cardiac patients -- Economic aspects, Health insurance -- Economic aspects, Surgery -- Economic aspects, Transluminal angioplasty -- Economic aspects, Health care industry
Abstract

2021 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health Insurance Week -- Researchers detail new data in Heart Disorders and Diseases - Acute Coronary Syndrome. According [...]

Published
2021

23. Diana Johnson ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 May 2019 to Question 256313, which services (a) NHS England, (b) clinical commissioning groups and (c) other public bodies commission for sickle cell disease patients with (i) stroke, (ii) chronic kidney disease, (iii) end-stage renal disease and (iv) pulmonary hypertension; and what the annual per capita cost is of providing each of those services

Subjects
Pulmonary hypertension -- Economic aspects, Sickle cell anemia -- Economic aspects, Chronic kidney failure -- Economic aspects, Hypertension, Kidney diseases, Stroke patients, Stroke, Business, international
Abstract

London: United Kingdom House of Commons has issued the following written answer: Answered by: Seema Kennedy Answered on: 19 July 2019 NHS England does not commission separate services for sickle [...]

Published
2019

24. Kidney Dialysis Equipment Market Vendor Landscape and Economic Growth 2024

Subjects
Hemodialysis -- Economic aspects, Chronic kidney failure -- Economic aspects, Kidney failure, Kidney diseases, General interest, News, opinion and commentary
Abstract

SEATTLE: Coherent Market Insights has issued the following news release: Chronic kidney disease (CKD) is a chronic condition that seriously affects the quality of life of the patient. Kidney dialysis [...]

Published
2019

25. Researchers at Pennsylvania State University (Penn State) Target End Stage Kidney Disease (Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis)

Subjects
Health care costs -- Economic aspects, Parathyroid hormones -- Economic aspects, Medical research -- Economic aspects, Vitamin D -- Economic aspects, Chronic kidney failure -- Economic aspects, Parks, Kidney diseases, Vitamins, Hyperparathyroidism, Editors, Diseases, Health, The Pennsylvania State University
Abstract

2020 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Kidney Diseases and Conditions - End Stage Kidney [...]

Published
2020

26. Excluded from universal coverage: ESRD patients not covered by Medicare

Author

Thamer, Mae, Ray, Nancy F., Richard, Christian, Greer, Joel W., Pearson, Brian C., and Cotter, Dennis J.

Subjects
Kidneys -- Transplantation, Chronic kidney failure -- Economic aspects, Medicaid -- Economic aspects, Dialysis -- Economic aspects, Business, Health care industry, Economic aspects
Abstract

Medicaid is believed to serve as the major insurer for end stage renal disease (ESRD) patients who are ineligible for Medicare coverage. Demographics, receipt of dialysis services, and costs of Medicaid-only populations were compared with Medicare ESRD populations in California, Georgia, and Michigan. Notable differences in patient demographics, dialysis practice patterns, and inpatient health resource utilization between the Medicaid and Medicare ESRD populations were observed. Medicaid expenditures for Medicare-ineligible ESRD patients were considerable: in 1991, California spent $46.4 million for 1,239 ESRD patients; Georgia and Michigan each spent nearly $5 million for approximately 140 ESRD patients., INTRODUCTION In terms of morbidity, mortality, and economic costs, ESRD is among the most serious chronic diseases in the United States (Institute of Medicine, 1991). ESRD results from the permanent [...]

Published
1995

27. Race and end-stage renal disease: socioeconomic status and access to health care as mediating factors

Author

Perneger, Thomas V., Whelton, Paul K., and Klag, Michael J.

Subjects
Chronic kidney failure -- Economic aspects, African Americans -- Diseases, Poverty -- Health aspects, Medical care -- Utilization, Health
Abstract

Objective: To examine whether lower socioeconomic status and limited access to health care explain the racial inequities in the incidence of end-stage renal disease (ESRD), and whether these factors are independently associated with ESRD. Methods: This case-control study compared 716 patients with ESRD with 361 population controls of the same age, 20 to 64 years old, from Maryland, Virginia, West Virginia, and Washington, DC. Race, indicators of socioeconomic status (household annual income, years of education), and indicators of access to health care (health insurance status, number of missing teeth, usual source of care, use of preventive services) were assessed via a telephone interview. Results: Independent risk factors for ESRD included nonwhite race (odds ratio for blacks, 5.5; 95% confidence interval, 3.8 to 8.0; odds ratio for other nonwhites, 3.5; 95% confidence interval, 1.2 to 10.0), categories of income (odds ratio gradient, 1.0 to 4.5; 95% confidence interval, 2.6 to 7.8), receipt of Medicaid benefits (odds ratio, 3.5; 95% confidence interval, 1.5 to 8.4), and number of missing teeth (odds ratio gradient, 1.0 to 2.2; 95% confidence interval, 1.2 to 4.1). Adjustment for socioeconomic variable reduced the odds ratio for blacks only partially, from 8.1 to 5.5. The proportions of ESRD incidence that could be attributed to each risk factor were 46% for minority race, 53% for income categories, and 33% for missing teeth. Conclusions: Low socioeconomic status and limited access to health care were strong risk factors for kidney failure, but they explained only part of the excess of ESRD in blacks. Racial and social factors account for a large part of ESRD incidence. The mechanisms of these associations should be targeted by further research. (Arch Intern Med. 1995; 155:1201-1208)

Published
1995

28. Reimbursement rates and quality of care in the dialysis industry: a policy discussion.

Author

Kaserman, David L.

Subjects
Chronic kidney failure -- Economic aspects, Patients -- Finance -- Economic aspects, Hemodialysis -- Equipment and supplies, Hemodialyzers -- Economic aspects, Company financing
Abstract

Under the end stage renal disease (ESRD) program, begun in 1972, the Health Care Financing Administration (HCFA) of the federal government covers 80% of the costs of dialysis for all [...]

Published
1992

30. Team-based care improves care for kidney disease, reduces costs by $1.2 million

Subjects
Patient care -- Economic aspects, Medical care quality -- Economic aspects, Medical economics -- Economic aspects, Health care reform -- Economic aspects, Chronic kidney failure -- Economic aspects, General interest, News, opinion and commentary
Abstract

ST. LOUIS PARK:HealthPartners has issued the following news release: A Park Nicollet program to improve care for more than 100 patients with end-stage kidney disease improved the quality of care [...]

Published
2017

31. Team-based care improves care for kidney disease, reduces costs by $1.2 million

Subjects
Patient care -- Economic aspects, Medical care quality -- Economic aspects, Medical economics -- Economic aspects, Health care reform -- Economic aspects, Chronic kidney failure -- Economic aspects, Business, Business, international
Abstract

Costly condition expected to grow as population ages ST. LOUIS PARK, Minn. -- A Park Nicollet program to improve care for more than 100 patients with end-stage kidney disease improved [...]

Published
2017

33. United States : Cigna and Fresenius Medical Care North America Collaborate to Drive Quality and Lower the Cost of Caring for Kidney Dialysis Patients

Subjects
CIGNA Corp., Insurance industry -- Economic aspects, Heart diseases -- Economic aspects, Health care industry -- Economic aspects, Family medicine -- Economic aspects, Medical care quality -- Economic aspects, Health care reform -- Economic aspects, Chronic kidney failure -- Economic aspects, Health care industry, Insurance industry, Business, international
Abstract

Cigna and Fresenius Medical Care North America have launched a national program to drive quality and lower the cost of care for people with end-stage kidney disease who are undergoing [...]

Published
2017

34. Cigna and Fresenius Medical Care North America Collaborate to Drive Quality and Lower the Cost of Caring for Kidney Dialysis Patients

Subjects
CIGNA Corp., Insurance industry -- Economic aspects, Health care industry -- Economic aspects, Medical care quality -- Economic aspects, Health care reform -- Economic aspects, Chronic kidney failure -- Economic aspects, Health care industry, Insurance industry, Business, Business, international
Abstract

* Value-based reimbursement model uses incentives to engage health care providers * Helps drive improved health, affordability and patient/provider experience * Cigna's first value-based reimbursement arrangement for kidney disease specialty [...]

Published
2017

35. New Peritoneal Dialysis Study Findings Recently Were Reported by Researchers at Baxter Healthcare Corporation (Remote Monitoring of Automated Peritoneal Dialysis Patients: Assessing Clinical and Economic Value)

Subjects
Baxter Healthcare Corp., Medical equipment industry -- Economic aspects, Medical research -- Economic aspects, Chronic kidney failure -- Economic aspects, Health
Abstract

2018 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Dialysis - Peritoneal Dialysis. According to news reporting [...]

Published
2018

36. CMS Issues Proposed CY 2017 Medicare ESRD PPS Update

Subjects
United States. Centers for Medicare and Medicaid Services -- Laws, regulations and rules, Medicare -- Laws, regulations and rules, Prospective payment systems (Medical care) -- Laws, regulations and rules, Chronic kidney failure -- Economic aspects, Government regulation, Business, international
Abstract

The Centers for Medicare & Medicaid Services (CMS) has published its proposed rule to update the Medicare end-stage renal disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2017. [...]

Published
2016

38. Helping patients with end-stage renal disease: changing policies from the bedside

Author

Kuchta, Kathleen, VanBuskirk, Suzann, and Houglum, Mary

Subjects
Medical care, Cost of -- Management, Chronic kidney failure -- Care and treatment, Chronic kidney failure -- Economic aspects, Nursing care -- Standards, Prospective payment systems (Medical care) -- Standards, Company business management, Health
Published
2007

39. Team-based care improves care for kidney disease, reduces costs by $1.2 million

Subjects
Patient care -- Economic aspects, Medical care quality -- Economic aspects, Medical economics -- Economic aspects, Health care reform -- Economic aspects, Chronic kidney failure -- Economic aspects, Health care industry, Law
Abstract

2017 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health Business Week -- A Park Nicollet program to improve care for more than 100 patients with end-stage [...]

Published
2017

40. Beyond Kidney Disease, Cost of Treatment is Bigger Killer [opinion]

Subjects
Chronic kidney failure -- Economic aspects, News, opinion and commentary
Abstract

Byline: Chioma Obinna Nov 03, 2015 (Vanguard/All Africa Global Media via COMTEX) -- Kidney disease is a worldwide problem but the magnitude in Nigeria is in a world of its [...]

Published
2015

41. Data on Kidney Transplants Reported by Researchers at Institute for Cancer Research and Treatment (IRCCS) (Cost-Effectiveness of Kidney Transplantation From DCD in Italy)

Subjects
Cancer -- Economic aspects, Cancer research -- Economic aspects, Kidney transplantation -- Economic aspects, Tissue donation -- Economic aspects, Chronic kidney failure -- Economic aspects, Health
Abstract

By a News Reporter-Staff News Editor at Blood Weekly -- Investigators discuss new findings in Transplant Medicine. According to news reporting out of Pavia, Italy, by NewsRx editors, research stated, [...]

Published
2015

42. Moderate kidney disease costs medicare tens of billions of dollars each year

Subjects
Medical economics -- Economic aspects, Medicare -- Economic aspects, Chronic kidney failure -- Economic aspects, General interest
Abstract

India, Aug. 3 -- Washington, DC (August 1, 2013) - Even early stages of kidney disease come with steep medical costs, according to a study appearing in an upcoming issue [...]

Published
2013

44. Controlling Chronic Kidney Disease Saves Lives and Money

Subjects
Chronic kidney failure -- Economic aspects, Business, News, opinion and commentary
Abstract

Low-Cost Lab Tests Help Slow a Disease Costing $60 Billion Annually WASHINGTON, Oct. 11, 2012 /PRNewswire-USNewswire/ -- There's little debate about one health care issue: Taking steps to control chronic [...]

Published
2012

45. ADDRESSING POVERTY THROUGH PARTNERSHIP

Subjects
Poverty -- Nicaragua -- Economic aspects, Chronic kidney failure -- Economic aspects, News, opinion and commentary, Presbyterian Church
Abstract

LOUISVILLE, Kentucky -- The following information was released by the Presbyterian Church (U.S.A.): There is something horrific going on in impoverished communities in Northwestern Nicaragua located near sugarcane estates: disease [...]

Published
2012

46. MEDICARE KIDNEY SPENDING AT CRUCIAL MOMENT

Subjects
Medicare -- Economic aspects, Medical economics -- Economic aspects, Chronic kidney failure -- Economic aspects, Cost control -- Economic aspects, Cost reduction, News, opinion and commentary, Brown University
Abstract

PROVIDENCE, R.I. -- The following information was released by Brown University: Amid a presidential campaign and facing the 'fiscal cliff,' Americans hear a lot about federal spending, particularly for Medicare. [...]

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results